NasdaqHealth CareServices-Medical LaboratoriesBROOMFIELD, CO

Aclarion, Inc. ACON

Ask your AI

Estimated market cap $4.50M2.88M shares, shares as of Nov 3, 2026CIK 1635077

Insider trades, 12 mo

11 buys · 0 sells

$176.6K bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

4.1% of shares · 3 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Aclarion, Inc.'s latest quarterly report, compared with the one before.

Filed Nov 5, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Aclarion, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

11 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 17, 2026. Insiders have two business days to file.

Recent insider trades

Amanda M. Williams Director	Aug 17 Form 4 ↗	Buy	+$16.0K 5,857 sh @ $2.73	-41.3%
Gregory A. Gould CFO	Aug 14 Form 4 ↗	Buy	+$24.5K 10,000 sh @ $2.45	-33.8%
Ryan Bond Director	Aug 13 Form 4 ↗	Buy	+$50.1K 21,122 sh @ $2.37	-32.0%
William Wesemann Director	Aug 13 Form 4 ↗	Buy	+$5,031 2,150 sh @ $2.34	-32.0%
Brent Ness Chief Executive Officer, Director	Aug 13 Form 4 ↗	Buy	+$12.1K 5,234 sh @ $2.31	-32.0%

All ACON insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

118,071 shares

11 funds report ACON. Values checked against market prices.

Funds own 4.0% of shares (Q2 2026)

15 funds hold the stock.

Q3 2026: 4.1% · 5,560 of ~8,900 funds reported so far

Q2 20250.3%
Q3 20253.3%
Q4 20252.6%
Q1 20264.9%
Q2 20264.0%
Q3 2026 (so far)4.1%

Q3 2026. 3 new, 3 added to, 1 trimmed, 7 exited since Q2 2026.

Top 13F holders
#
1	Captrust Financial Advisors 13F ↗	40,000	$96.4K	+134.5%
2	Vanguard Fiduciary Trust Co 13F ↗	16,028	$38.6K	unchanged
3	Jane Street Group, LLC 13F ↗	14,687	$35.4K	New
4	Geode Capital Management, LLC 13F ↗	12,068	$29.1K	-0.5%
5	Mosaic Family Wealth Partners, LLC 13F ↗	10,000	$24.1K	New
6	Bank of Montreal 13F ↗	10,000	$24.1K	unchanged
7	Osaic Holdings, Inc. 13F ↗	7,500	$18.1K	+50.0%
8	Vanguard Capital Management LLC 13F ↗	6,782	$16.3K	unchanged
9	FMR LLC 13F ↗	1,000	$2,410	New
10	Caitong International Asset Management Co., Ltd 13F ↗	5	$12	+25.0%

Download CSV Every fund that holds ACON, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Aclarion, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Aclarion, Inc. and its lobbying firms report each quarter.

Loading…

H-1B labor applications at Aclarion, Inc.

2 certified in 12 mo

Labor condition applications decided by the Department of Labor, matched to Aclarion, Inc. by employer name. An application is not a hire.

Median yearly wage offered, full-time certified applications, Jul 2025 to Jun 2026: —

H-1B labor applications decided at Aclarion, Inc. by quarter
Quarter	Certified	All decided	Workers asked for
2024 Q3	0	0	0
2024 Q4	0	0	0
2025 Q1	0	0	0
2025 Q2	0	0	0
2025 Q3	0	0	0
2025 Q4	0	0	0
2026 Q1	0	0	0
2026 Q2	2	2	2

Most common job titles at Aclarion, Inc.

Forward Deployed Engineer	1	—
Founding Software Engineer	1	—

All ACON applications

We match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly. The files carry no worker names.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2025	6	—	68	$734
Q2 2025	5	-1	1,816	$13.7K
Q3 2025	8	+3	22,399	$168.0K
Q4 2025	8	0	17,424	$80.2K
Q1 2026	10	+2	112,575	$368.1K
Q2 2026	15	+5	115,329	$332.1K
Q3 2026	11	-4	118,071	$284.6K

Each point is a quarter-end, from Q1 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (655187409). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes1 in 12 mo 8-K eventsNone in 90 days Patents5 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials1 active IPO history7 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Aclarion, Inc.
Address: 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO 80021
Phone: 833 275 2266
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company, emerging growth company
Incorporated in: DE
Listed as: ACON (Nasdaq), ACONW (Nasdaq)
Former names: Nocimed, Inc. (until 2021)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.56−$0.03 (−1.89%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $1.56 · High $2.14Nov 13, 2026

Aug 13, 2026Low $1.56 · High $2.94Nov 13, 2026

Nov 13, 2025Low $1.56 · High $8.17Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.